StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Medline Inc (MDLN) PT Lowered to $45 at Baird
June 3, 2026 6:16 AM
Baird analyst Eric Coldwell lowered the price target on Medline Inc (NASDAQ:
MDLN
) to $45.00 (from $57.00) while maintaining a Outperform rating.
Categories
Analyst PT Change